0001225208-12-016683.txt : 20120726
0001225208-12-016683.hdr.sgml : 20120726
20120726161634
ACCESSION NUMBER: 0001225208-12-016683
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20120720
FILED AS OF DATE: 20120726
DATE AS OF CHANGE: 20120726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elicker John E
CENTRAL INDEX KEY: 0001554788
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 12987624
MAIL ADDRESS:
STREET 1: BRISTOL-MYERS SQUIBB COMPANY
STREET 2: ROUTE 206 & PROVINCELINE ROAD
CITY: LAWRENCEVILLE
STATE: NJ
ZIP: 08543
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
3
1
doc3.xml
X0206
3
2012-07-20
0
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001554788
Elicker John E
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
1
SVP Pub Affairs & Inv Relation
Common Stock, $0.10 par value
24675.5000
D
Market Share Units
2015-03-01
Common Stock, $0.10 par value
4080.0000
D
Market Share Units
2014-03-02
Common Stock, $0.10 par value
2753.0000
D
Market Share Units
2016-03-06
Common Stock, $0.10 par value
4172.0000
D
Option (right to buy)
17.5100
2019-03-02
Common Stock, $0.10 par value
19723.0000
D
Option (right to buy)
22.1400
2018-03-03
Common Stock, $0.10 par value
7377.0000
D
Option (right to buy)
27.0100
2017-03-05
Common Stock, $0.10 par value
6615.0000
D
Option (right to buy)
28.1100
2014-03-01
Common Stock, $0.10 par value
16875.0000
D
Performance Shares
2013-03-31
Common Stock, $0.10 par value
7720.7700
D
Performance Shares
2014-03-31
Common Stock, $0.10 par value
3976.9300
D
Restricted Stock Units
2017-01-03
Common Stock, $0.10 par value
2852.0000
D
Restricted Stock Units
2013-03-03
Common Stock, $0.10 par value
1851.0000
D
Restricted Stock Units
2014-05-03
Common Stock, $0.10 par value
3017.0000
D
1,360 market share units will vest on each of March 1, 2013, March 1, 2014 and March 1, 2015.
Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.
1,376 market share units will vest on March 2, 2013 and 1,377 market share units will vest on March 2, 2014.
Twenty-five percent of the market share unit award will vest on each of the first, second, third, and fourth anniversaries of the grant date, starting on March 6, 2013.
9,882 shares are currently exercisable. The remaining 9,841 shares will become exercisable on March 3, 2013.
All of the shares are currently exercisable.
Consists of 7,145 performance shares and 575.77 performance shares representing dividend equivalents earned under the 2010-2012 Long Term Performance Award.
Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.
Consists of 3,767 performance shares and 209.93 performance shares representing dividend equivalents earned under the 2011-2013 Long Term Performance Award.
Each performance share converts into one share of common stock upon distribution in the first quarter of 2014.
952 restricted stock units will vest on January 3, 2015, and 950 restricted stock units will vest on each of January 3, 2016 and January 3, 2017.
Each restricted stock unit converts into one share of common stock upon vesting.
These restricted stock units will vest on March 3, 2013.
1,508 restricted stock units will vest on May 3, 2013 and 1,509 restricted stock units will vest on May 3, 2014.
Exhibit 24 - Power of Attorney
/s/ John E. Elicker
2012-07-26
EX-24
2
elicker_poa.txt
Exhibit 24
POWER OF ATTORNEY
I, John E. Elicker, Senior Vice President, Public Affairs and Investor
Relations, of Bristol-Myers Squibb Company (the "Company"),a corporation duly
organized and existing under the laws of the State of Delaware, in the
United States of America, and having its principal place of business at
345 Park Avenue, New York, New York, do hereby constitute and appoint each of
Sandra Leung, Katherine R. Kelly, and Robert J. Wollin, individually, as my
lawful attorney-in-fact and in my name, place and stead to execute and deliver
any and all documents relating to insider reporting requirements under
Section 16 of the Securities Exchange Act of 1934, with respect to securities
issued by the Company, including, without limitation, the execution and filing
of all Forms 3, 4 and 5, and to take such other action, as such attorney
considers necessary or appropriate, to effectuate such transactions. This Power
of Attorney shall remain in full force and effect until I am no longer required
to file Forms 3, 4, and 5 with respect to securities issued by the Company,
unless earlier revoked.
IN WITNESS WHEREOF, I have executed this Power of Attorney on this
23rd day of July, 2012.
/s/ John E. Elicker
John E. Elicker